IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Neuropeptides

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

3.02

h-Index

2022-2023

 75

Rank

2022-2023

 6885

SJR

2022-2023

 0.719

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Neuropeptides
Abbreviation Neuropeptides
Publication Type Journal
Subject Area, Categories, Scope Endocrine and Autonomic Systems (Q2); Endocrinology (Q2); Medicine (miscellaneous) (Q2); Neurology (Q2); Cellular and Molecular Neuroscience (Q3)
h-index 75
Overall Rank/Ranking 6885
SCImago Journal Rank (SJR) 0.719
Impact Score 3.02
Publisher Churchill Livingstone
Country United States
ISSN 15322785, 01434179
Best Quartile Q2
Coverage History 1980-2022




About Neuropeptides


Neuropeptides is a journal covering the technologies/fields/categories related to Endocrine and Autonomic Systems (Q2); Endocrinology (Q2); Medicine (miscellaneous) (Q2); Neurology (Q2); Cellular and Molecular Neuroscience (Q3). It is published by Churchill Livingstone. The overall rank of Neuropeptides is 6885. According to SCImago Journal Rank (SJR), this journal is ranked 0.719. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 75. The best quartile for this journal is Q2.

The ISSN of Neuropeptides journal is 15322785, 01434179. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Neuropeptides is cited by a total of 575 articles during the last 3 years (Preceding 2022).


Neuropeptides Impact IF 2022-2023


The Impact IF 2022 of Neuropeptides is 3.02, which is computed in 2023 as per its definition. Neuropeptides IF is decreased by a factor of 0.08 and approximate percentage change is -2.58% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Neuropeptides Impact IF 2023 Prediction


Impact IF 2022 of Neuropeptides is 3.02. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Neuropeptides. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 3.02
2021 3.10
2020 2.98
2019 2.48
2018 2.52
2017 3.13
2016 2.31
2015 2.83
2014 2.91

Neuropeptides h-index


  Table Setting

Neuropeptides has an h-index of 75. It means 75 articles of this journal have more than 75 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Neuropeptides ISSN


The ISSN of Neuropeptides is 15322785, 01434179. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Neuropeptides Rank and SCImago Journal Rank (SJR)


The overall rank of Neuropeptides is 6885. According to SCImago Journal Rank (SJR), this journal is ranked 0.719. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Neuropeptides by Year


Year SJR
2023/2024 Coming Soon
2022 0.719
2021 0.726
2020 0.830
2019 0.814
2018 0.818
2017 1.038
2016 1.017
2015 1.209
2014 1.030

Ranking of Neuropeptides by Year


Year Ranking
2023/2024 Coming Soon
2022 6885
2021 6544
2020 5749
2019 5787
2018 5753
2017 4158
2016 4324
2015 3379
2014 4168

Neuropeptides Publisher


Table Setting

Neuropeptides is published by Churchill Livingstone. It's publishing house is located in United States. Coverage history of this journal is as following: 1980-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Neuropeptides is Neuropeptides. This abbreviation ('Neuropeptides') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Neuropeptides


If your research field is/are related to Endocrine and Autonomic Systems (Q2); Endocrinology (Q2); Medicine (miscellaneous) (Q2); Neurology (Q2); Cellular and Molecular Neuroscience (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Neuropeptides?

Neuropeptides latest impact IF is 3.02. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.13 (2017) and 2.31 (2016), respectively, in the last 9 years. Moreover, its average IS is 2.81 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Neuropeptides?

The Neuropeptides has an SJR (SCImago Journal Rank) of 0.719, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.209 in 2015 and the lowest being 0.719 in 2022. Furthermore, the average SJR of the Neuropeptides over the previous 9-year period stands at 2.81.


What's the latest h-index of the Neuropeptides?

The latest h-index of the Neuropeptides is 75.


Who's the publisher of the Neuropeptides?

The Neuropeptides is published by the Churchill Livingstone, with its country of publication being the United States.


What's the current ranking of the Neuropeptides?

The Neuropeptides is currently ranked 6885 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 3379 in 2015 and its lowest position of 6885 in 2022.


What's the abbreviation or short name for the Neuropeptides?

The standard ISO4 abbreviation for the Neuropeptides is Neuropeptides.


Is the "Neuropeptides" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Neuropeptides is classified as a journal that the Churchill Livingstone publishes.


What's the scope or major areas of the Neuropeptides?

The Neuropeptides encompasses the following areas:

  • Endocrine and Autonomic Systems
  • Endocrinology
  • Medicine (miscellaneous)
  • Neurology
  • Cellular and Molecular Neuroscience

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Neuropeptides?

The Neuropeptides is assigned the following International Standard Serial Numbers (ISSN): 15322785, 01434179.


What's the best quartile of the Neuropeptides?

The best quartile for the Neuropeptides is Q2 (2022).


What's the coverage history of the Neuropeptides?

The Neuropeptides coverage history can be summarized as follows: 1980-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division conference and proceedings 17477 16 0.00
Applied Ecology and Environmental Research journal 17545 Corvinus University of Budapest 38 0.74
SPE Production and Operations Symposium, Proceedings conference and proceedings 15907 21 0.00
Socialism and Democracy journal 26162 Taylor and Francis Ltd. 17 0.09
Syntax journal 3422 Wiley-Blackwell Publishing Ltd 29 0.93
Transnational Corporations journal 6120 UNCTAD United Nations Conference on Trade and Development 27 1.92
Sapporo Medical Journal journal 20468 Cancer Research Institute, Sapporo Medical University 3 0.00
Population Review journal 17841 Sociological Demography Press 13 0.73
Exploration Geophysics journal 16383 Taylor and Francis Ltd. 48 1.17
Proceedings of the Royal Society of Queensland journal 22998 Royal Society of Queensland 12 0.48

Check complete list




Year wise Impact Score (IS) of Neuropeptides

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 3.02
2021 3.10
2020 2.98
2019 2.48
2018 2.52
2017 3.13
2016 2.31
2015 2.83
2014 2.91



Top Journals/Conferences in Endocrine and Autonomic Systems

Brain, Behavior, and Immunity
Academic Press Inc. | United States

Frontiers in Neuroendocrinology
Academic Press Inc. | United States

Neurobiology of Stress
Elsevier BV | Netherlands

Neurogastroenterology and Motility
Wiley-Blackwell Publishing Ltd | United Kingdom

Psychoneuroendocrinology
Elsevier Ltd. | United Kingdom

Psychophysiology
Wiley-Blackwell Publishing Ltd | United Kingdom

Clinical Autonomic Research
D. Steinkopff-Verlag | Germany

Hormones and Behavior
Academic Press Inc. | United States

Neuroendocrinology
S. Karger AG | Switzerland

Journal of Neuroendocrinology
Wiley-Blackwell Publishing Ltd | United Kingdom

See All

Top Journals/Conferences in Endocrinology

Lancet Diabetes and Endocrinology,The
Elsevier Ltd. | United Kingdom

Nature Reviews Endocrinology
Nature Publishing Group | United Kingdom

Endocrine Reviews
The Endocrine Society | United States

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

Diabetologia
Springer Verlag | Germany

Metabolism: Clinical and Experimental
W.B. Saunders Ltd | United Kingdom

Obesity Reviews
Wiley-Blackwell Publishing Ltd | United Kingdom

Diabetes
American Diabetes Association Inc. | United States

Cytokine and Growth Factor Reviews
Elsevier BV | United Kingdom

See All

Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Neurology

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

See All

Top Journals/Conferences in Cellular and Molecular Neuroscience

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Molecular Psychiatry
Nature Publishing Group | United Kingdom

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Translational Neurodegeneration
BioMed Central Ltd. | United Kingdom

Journal of Neuroinflammation
BioMed Central Ltd. | United Kingdom

Acta neuropathologica communications
BioMed Central Ltd. | United Kingdom

GLIA
John Wiley & Sons Inc. | United States

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

See All